Literature DB >> 28210747

Extent of field change in colorectal cancers with BRAF mutation.

Aaron Poh1, Heidi Sian Ying Chang2, Kok Yang Tan1, Xin Xiu Sam3, Avery Khoo3, Shoa Nian Choo4, Min En Nga4, Wei Keat Wan5.   

Abstract

INTRODUCTION: Sporadic colorectal cancers with BRAF mutations constitute two distinct subgroups of colorectal cancers. Recent studies have linked the presence of the BRAF mutation to a familial inheritance pattern. This was a proof-of-concept study that aimed to examine: (a) the extent of field change in sporadic colorectal cancers with BRAF mutation; and (b) the extent of resection margins required and the pattern of DNA mismatch repair protein loss in these tumours.
METHODS: Eight microsatellite instability-high tumours with positive BRAF mutation from an existing histopathological database were selected for BRAF mutation and mismatch repair protein analysis.
RESULTS: All the resection margins were negative for BRAF mutation. Three tumours had loss of MLH1 and PMS2 expressions, and five tumours had no protein loss. Six peritumoral tissues were negative and one was positive for BRAF mutation.
CONCLUSION: The results suggest that any early field change effect is restricted to the immediate vicinity of the tumour and is not a pan-colonic phenomenon. Current guidelines on resection margins are adequate for BRAF mutation-positive colorectal cancers. Any suggestion of a hereditary link to these tumours is likely not related to germline BRAF gene mutations. The pattern of protein loss reinforces previous findings for the two subgroups of BRAF mutation-positive colorectal cancers. Copyright: © Singapore Medical Association.

Entities:  

Keywords:  BRAF mutation; colorectal cancer

Mesh:

Substances:

Year:  2017        PMID: 28210747      PMCID: PMC5861336          DOI: 10.11622/smedj.2017012

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  20 in total

Review 1.  Four molecular subtypes of colorectal cancer and their precursor lesions.

Authors:  Gyeong Hoon Kang
Journal:  Arch Pathol Lab Med       Date:  2011-06       Impact factor: 5.534

2.  Somatic BRAF-V600E mutations in familial colorectal cancer.

Authors:  Jana Vandrovcova; Kristina Lagerstedt-Robinsson; Lars Påhlman; Annika Lindblom
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-11       Impact factor: 4.254

Review 3.  Classification of colorectal cancer based on correlation of clinical, morphological and molecular features.

Authors:  J R Jass
Journal:  Histopathology       Date:  2007-01       Impact factor: 5.087

4.  Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer.

Authors:  Wade S Samowitz; Hans Albertsen; Jennifer Herrick; Theodore R Levin; Carol Sweeney; Maureen A Murtaugh; Roger K Wolff; Martha L Slattery
Journal:  Gastroenterology       Date:  2005-09       Impact factor: 22.682

5.  Evidence for BRAF mutation and variable levels of microsatellite instability in a syndrome of familial colorectal cancer.

Authors:  Joanne Young; Melissa A Barker; Lisa A Simms; Michael D Walsh; Kelli G Biden; Daniel Buchanan; Ron Buttenshaw; Vicki L J Whitehall; Sven Arnold; Leigh Jackson; Takeshi Kambara; Kevin J Spring; Mark A Jenkins; Graeme J Walker; John L Hopper; Barbara A Leggett; Jeremy R Jass
Journal:  Clin Gastroenterol Hepatol       Date:  2005-03       Impact factor: 11.382

6.  Evidence for field effect cancerization in colorectal cancer.

Authors:  L Hawthorn; L Lan; W Mojica
Journal:  Genomics       Date:  2013-12-04       Impact factor: 5.736

7.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.

Authors:  Asad Umar; C Richard Boland; Jonathan P Terdiman; Sapna Syngal; Albert de la Chapelle; Josef Rüschoff; Richard Fishel; Noralane M Lindor; Lawrence J Burgart; Richard Hamelin; Stanley R Hamilton; Robert A Hiatt; Jeremy Jass; Annika Lindblom; Henry T Lynch; Païvi Peltomaki; Scott D Ramsey; Miguel A Rodriguez-Bigas; Hans F A Vasen; Ernest T Hawk; J Carl Barrett; Andrew N Freedman; Sudhir Srivastava
Journal:  J Natl Cancer Inst       Date:  2004-02-18       Impact factor: 13.506

8.  BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas.

Authors:  Tsun L Chan; Wei Zhao; Suet Y Leung; Siu T Yuen
Journal:  Cancer Res       Date:  2003-08-15       Impact factor: 12.701

9.  Association of the CpG island methylator phenotype with family history of cancer in patients with colorectal cancer.

Authors:  Marsha L Frazier; Lixuan Xi; Jihong Zong; Nancy Viscofsky; Asif Rashid; Elsie F Wu; Patrick M Lynch; Christopher I Amos; Jean-Pierre J Issa
Journal:  Cancer Res       Date:  2003-08-15       Impact factor: 12.701

10.  Clinical implications and utility of field cancerization.

Authors:  Gabriel D Dakubo; John P Jakupciak; Mark A Birch-Machin; Ryan L Parr
Journal:  Cancer Cell Int       Date:  2007-03-15       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.